<div id="readability-page-1">May 7 (Reuters) - Siemens Healthineers on Thursday cut its full year outlook to forecast revenue growth of between 4.5% and 5.0% for the 2026 financial year citing the structural change in the Chinese Diagnostics markets and more pronounced inflation assumptions during the quarter. The Chinese market accounts for around 10 percent of the company's total revenue with volume-based procurement and</div>

<p>西门子医疗已修订其 2026 年的财务展望，现在预计收入增长为 4.5% 至 5.0%。这一调整归因于中国诊断市场的结构性变化和通胀预期的上升。中国市场约占公司总收入的 10%</p>

西门子医疗削减 2026 年预期